首页> 外文OA文献 >Outcomes following revision surgery performed for adverse reactions to metal debris in non-metal-on-metal hip arthroplasty patients: analysis of 185 revisions from the National Joint Registry for England and Wales
【2h】

Outcomes following revision surgery performed for adverse reactions to metal debris in non-metal-on-metal hip arthroplasty patients: analysis of 185 revisions from the National Joint Registry for England and Wales

机译:非金属对金属髋关节置换术患者对金属碎片的不良反应进行翻修手术后的结果:英格兰和威尔士国家联合登记处对185个翻修的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Few studies have assessed outcomes following non-metal-on-metal hip arthroplasty (nonMoMHA)revision surgery performed for adverse reactions to metal debris (ARMD). Weassessed outcomes following non-MoMHA revision surgery performed for ARMD, and identifiedpredictors of re-revision.We performed a retrospective observational study using data from the National Joint Registryfor England and Wales. All non-MoMHAs undergoing revision surgery for ARMD between2008 and 2014 were included (185 hips in 185 patients). Outcome measures followingARMD revision were intra-operative complications, mortality and re-revision surgery. Predictorsof re-revision were identified using Cox regression.Intra-operative complications occurred in 6.0% (n = 11) of the 185 cases. The cumulativefour-year patient survival rate was 98.2% (95% CI 92.9 to 99.5). Re-revision surgery wasperformed in 13.5% (n = 25) of hips at a mean time of 1.2 years (0.1 to 3.1 years) followingARMD revision. Infection (32%; n = 8), dislocation/subluxation (24%; n = 6), and asepticloosening (24%; n = 6) were the most common re-revision indications. The cumulative fouryearimplant survival rate was 83.8% (95% CI 76.7 to 88.9). Multivariable analysis identifiedthree predictors of re-revision: multiple revision indications (hazard ratio (HR) = 2.78; 95%CI 1.03 to 7.49; p = 0.043); selective component revisions (HR = 5.76; 95% CI 1.28 to 25.9;p = 0.022); and ceramic-on-polyethylene revision bearings (HR = 3.08; 95% CI 1.01 to 9.36;p = 0.047).Non-MoMHAs revised for ARMD have a high short-term risk of re-revision, with importantpredictors of future re-revision including selective component revision, multiple revisionindications, and ceramic-on-polyethylene revision bearings. Our findings may help counselpatients about the risks of ARMD revision, and guide reconstructive decisions. Future studiesattempting to validate the predictors identified should also assess the effects of implantdesign (metallurgy and modularity), given that this was an important study limitationpotentially influencing the reported prognostic factors.
机译:很少有研究评估非金属对金属髋关节置换术(nonMoMHA)修复手术对金属碎片(ARMD)的不良反应的结果。我们对非MoMHA进行ARMD修订手术后的结果进行了评估,并确定了重新修订的预测因素。我们使用了来自英国和威尔士国家联合登记处的数据进行了回顾性观察研究。纳入所有在2008年至2014年之间接受ARMD翻修手术的非MoMHA(185例患者中的185髋)。修订ARMD后的结果指标为术中并发症,死亡率和再次手术。使用Cox回归确定翻修的预测因素。185例中有6.0%(n = 11)发生术中并发症。四年患者累计生存率为98.2%(95%CI为92.9至99.5)。进行ARMD翻修后,平均13.5%(n = 25)的髋关节进行了翻修手术,平均时间为1.2年(0.1至3.1年)。最常见的修订指征是感染(32%; n = 8),脱位/半脱位(24%; n = 6)和无菌性松动(24%; n = 6)。累计四年种植体存活率为83.8%(95%CI为76.7至88.9)。多变量分析确定了三种修订的预测指标:多种修订指示(危险比(HR)= 2.78; 95%CI 1.03至7.49; p = 0.043);选择性成分修订(HR = 5.76; 95%CI 1.28至25.9; p = 0.022);以及用于聚乙烯的陶瓷改型轴承(HR = 3.08; 95%CI 1.01至9.36; p = 0.047)。为ARMD改版的非MoMHA具有很高的短期改版风险,并且是未来改版的重要预测因素包括选择性组件修订,多个修订指示以及聚乙烯上陶瓷修订轴承。我们的发现可能会帮助咨询患者关于ARMD修订的风险,并指导重建决策。鉴于这是一项重要的研究局限性,可能会影响所报告的预后因素,因此,未来旨在验证确定的预测因素的研究也应评估植入物设计的效果(冶金学和模块性)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号